These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
313 related items for PubMed ID: 20837708
1. Cyclic AMP controls mTOR through regulation of the dynamic interaction between Rheb and phosphodiesterase 4D. Kim HW, Ha SH, Lee MN, Huston E, Kim DH, Jang SK, Suh PG, Houslay MD, Ryu SH. Mol Cell Biol; 2010 Nov; 30(22):5406-20. PubMed ID: 20837708 [Abstract] [Full Text] [Related]
2. Rheb Inhibits Beiging of White Adipose Tissue via PDE4D5-Dependent Downregulation of the cAMP-PKA Signaling Pathway. Meng W, Liang X, Chen H, Luo H, Bai J, Li G, Zhang Q, Xiao T, He S, Zhang Y, Xu Z, Xiao B, Liu M, Hu F, Liu F. Diabetes; 2017 May; 66(5):1198-1213. PubMed ID: 28242620 [Abstract] [Full Text] [Related]
3. cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity. Xie J, Ponuwei GA, Moore CE, Willars GB, Tee AR, Herbert TP. Cell Signal; 2011 Dec; 23(12):1927-35. PubMed ID: 21763421 [Abstract] [Full Text] [Related]
18. Rheb protein binds CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamoylase, and dihydroorotase) protein in a GTP- and effector domain-dependent manner and influences its cellular localization and carbamoyl-phosphate synthetase (CPSase) activity. Sato T, Akasu H, Shimono W, Matsu C, Fujiwara Y, Shibagaki Y, Heard JJ, Tamanoi F, Hattori S. J Biol Chem; 2015 Jan 09; 290(2):1096-105. PubMed ID: 25422319 [Abstract] [Full Text] [Related]
19. Tumorigenic activity and therapeutic inhibition of Rheb GTPase. Mavrakis KJ, Zhu H, Silva RL, Mills JR, Teruya-Feldstein J, Lowe SW, Tam W, Pelletier J, Wendel HG. Genes Dev; 2008 Aug 15; 22(16):2178-88. PubMed ID: 18708578 [Abstract] [Full Text] [Related]